Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01

0 avis

Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01

Archive ouverte

Edité par CCSD ; American Association for the Advancement of Science (AAAS) -

International audience. An oncolytic adenovirus shows antitumor efficacy in patient-derived models of intraocular retinoblastoma and appears safe for human use.

Langue: en

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

A high-risk retinoblastoma subtype with stemness features, dedifferentiated cone states and neuronal/ganglion cell gene expression

Archive ouverte | Liu, Jing | CCSD

International audience. Retinoblastoma is the most frequent intraocular malignancy in children, originating from a maturing cone precursor in the developing retina. Little is known on the molecular basis underlying ...

A Parent-of-Origin Effect Impacts the Phenotype in Low Penetrance Retinoblastoma Families Segregating the c.1981C>T/p.Arg661Trp Mutation of RB1

Archive ouverte | Eloy, Philippine | CCSD

International audience. Retinoblastoma (Rb), the most common pediatric intraocular neoplasm, results from inactivation of both alleles of the RB1 tumor suppressor gene. The second allele is most commonly lost, as de...

Repurposing Vandetanib plus Everolimus for the Treatment of ACVR1 -Mutant Diffuse Intrinsic Pontine Glioma

Archive ouverte | Carvalho, Diana | CCSD

International audience. Abstract Somatic mutations in ACVR1 are found in a quarter of children with diffuse intrinsic pontine glioma (DIPG), but there are no ACVR1 inhibitors licensed for the disease. Using an artif...

Chargement des enrichissements...